DNAA
Social Capital Suvretta Holdings Corp I - Ordinary Shares - Class A

532
Loading...
Loading...
Akili, Inc. is a digital medicine company, which engages in the development of cognitive treatments through technologies. Its technologies are designed to directly target the physiology of the brain. The company was founded by W. Edward Martucci II and Adam Gazzaley in December 2020 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Akili Inc - Ordinary Shares - Class A?
What is the 52-week high for Akili Inc - Ordinary Shares - Class A?
What is the 52-week low for Akili Inc - Ordinary Shares - Class A?
What is Akili Inc - Ordinary Shares - Class A stock price today?
What was Akili Inc - Ordinary Shares - Class A stock price yesterday?
What is the PE ratio of Akili Inc - Ordinary Shares - Class A?
What is the Price-to-Book ratio of Akili Inc - Ordinary Shares - Class A?
What is Akili Inc - Ordinary Shares - Class A's EBITDA?
What is the 50-day moving average of Akili Inc - Ordinary Shares - Class A?

Latest DNAA News

View
No DNAA news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.